Stoke Therapeutics, Inc. STOK Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$169.77M-2,366% | -$6.89M-117% | $40.57M-22.7% | $52.48M+4.4% | $50.27M+156% | ||
| $1.73M-2.1% | $1.77M-6.4% | $1.89M-4.9% | $1.99M-4.9% | $2.09M-4.0% | ||
| $34.24M+6.2% | $32.24M+9.2% | $29.53M+1.9% | $28.98M+0.6% | $28.81M+4.9% | ||
| —— | —— | —— | —— | $69.54M+180% | ||
| $871K+30.0% | $670K+39.6% | $480K+6.4% | $451K+31.5% | $343K+69.0% | ||
| -$158.84M+18.9% | -$195.91M-45.3% | -$134.85M+18.2% | -$164.85M-57.5% | -$104.65M+3.4% | ||
| $180.34M+85.2% | $97.39M+1,634% | $5.62M-47.3% | $10.66M-91.9% | $130.75M-0.3% | ||
| -$117.06M-162% | -$44.66M+32.8% | -$66.47M+27.6% | -$91.78M-195% | $96.46M+253% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Stoke Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Stoke Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.